Last reviewed · How we verify
Moderately active ulcerative colitis
Approved treatments
- MESALAMINE
Mesalamine reduces inflammation in the colon by blocking cyclooxygenase and inhibiting prostaglandin production.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Moderately active ulcerative colitis patent landscape — cliff calendar, originator estates, attackable patents
- Moderately active ulcerative colitis treatment landscape brief
- Moderately active ulcerative colitis treatment updates RSS
Frequently asked questions about Moderately active ulcerative colitis
What drugs treat Moderately active ulcerative colitis?
Tracked treatments include MESALAMINE.
What is the treatment for Moderately active ulcerative colitis?
Standard treatment for Moderately active ulcerative colitis includes MESALAMINE. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Moderately active ulcerative colitis patent cliff · Moderately active ulcerative colitis CI report
- Treatment: MESALAMINE
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing